{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:02:52Z","timestamp":1780077772177,"version":"3.54.0"},"reference-count":50,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMICR"],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lack of standardized criteria for discontinuing contact precautions (CP) in patients colonized or infected with multidrug-resistant bacteria (MDRB) can prolong isolation and strain healthcare resources. This retrospective cohort study aimed to assess the safety of a protocol-guided CP discontinuation strategy and identify risk factors for MDRB reacquisition. The study evaluated 88 adult patients under CP who met an institutional protocol for CP discontinuation between 2018 and 2023. The protocol required: no active infection; no antibiotic use in the preceding seven days; no drains or open wounds; no diarrhea; a negative culture from the initial site of MDRB identification; and a subsequent confirmatory negative screening (culture and\/or PCR). Patients were followed for one year after CP discontinuation to assess MDRB reacquisition, defined as a new positive specimen for the same species. Potential risk factors for reacquisition were analyzed using multivariable Cox regression. At the one-year follow-up, MDRB reacquisition occurred in 17% (15\/88) of patients. The reacquired pathogens included carbapenem-resistant Enterobacterales (9\/50), methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (6\/30), and vancomycin-resistant\n                    <jats:italic>Enterococcus<\/jats:italic>\n                    spp. (0\/8). Independent risk factors for reacquisition were chronic obstructive pulmonary disease (HR 5.76, 95% CI 1.34\u201324.81), shorter duration of isolation (HR 0.98 per day, 95% CI 0.97\u20130.99), frequent hospitalizations (HR 1.75 per admission, 95%\u00a0CI\u00a01.07\u20132.88), and central venous catheterization (HR 13.04, 95% CI 2.63\u201364.69). Protocol-guided CP\u00a0discontinuation was associated with a low rate of MDRB reacquisition and appears safe in appropriately selected patients. This approach may reduce unnecessary isolation in eligible patients, though high-risk individuals require closer monitoring.\n                  <\/jats:p>","DOI":"10.1556\/030.2026.02900","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T13:37:49Z","timestamp":1774013869000},"page":"194-200","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["Safety of discontinuing contact precautions in\u00a0patients with multidrug-resistant bacterial infection or colonization"],"prefix":"10.1556","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-9765","authenticated-orcid":true,"given":"Muhammed Cihan","family":"I\u015f\u0131k","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-3345","authenticated-orcid":true,"given":"G\u00fcl\u00e7in","family":"Telli Dizman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"},{"name":"Infection Control Committee, Hospitals of Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Dilek","family":"G\u00fcl","sequence":"additional","affiliation":[{"name":"Infection Control Committee, Hospitals of Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lknur","family":"Tekin Demir","sequence":"additional","affiliation":[{"name":"Infection Control Committee, Hospitals of Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanife","family":"Ayta\u00e7 Ak","sequence":"additional","affiliation":[{"name":"Infection Control Committee, Hospitals of Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-4085","authenticated-orcid":true,"given":"P\u0131nar","family":"Zarakolu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2676-4557","authenticated-orcid":true,"given":"G\u00f6khan","family":"Metan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"},{"name":"Infection Control Committee, Hospitals of Faculty of Medicine, Hacettepe University, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"B1","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli E","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et\u00a0al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20: 1\u201355. 10.1111\/1469-0691.12427https:\/\/doi.org\/10.1111\/1469-0691.12427"},{"issue":"5","key":"B2","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"470 e1","DOI":"10.1016\/j.cmi.2014.12.015","article-title":"Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders\u00a0and rectal KPC concentration","volume":"21","author":"Lerner A","year":"2015","unstructured":"Lerner A, Adler A, Abu-Hanna J, Cohen Percia S, Kazma Matalon M, Carmeli Y. Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders\u00a0and rectal KPC concentration. Clin Microbiol Infect 2015; 21(5): 470 e1\u20137. 10.1016\/j.cmi.2014.12.015https:\/\/doi.org\/10.1016\/j.cmi.2014.12.015"},{"issue":"1","key":"B3","series-title":"Antimicrob Steward Healthc Epidemiol","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2025.173","article-title":"Prioritizing isolation precautions: a patient-centered approach to infection prevention and control","volume":"5","author":"Alp Mese E","year":"2025","unstructured":"Alp Mese E, Carrara E, Tartari E, Mutters NT, Tsioutis C, Birgand G, et\u00a0al. Prioritizing isolation precautions: a patient-centered approach to infection prevention and control. Antimicrob Steward Healthc Epidemiol 2025; 5(1): e123. 10.1017\/ash.2025.173https:\/\/doi.org\/10.1017\/ash.2025.173"},{"issue":"10","key":"B4","series-title":"J\u00a0Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/jac\/dkw221","article-title":"Natural history and\u00a0decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis","volume":"71","author":"Bar-Yoseph H","year":"2016","unstructured":"Bar-Yoseph H, Hussein K, Braun E, Paul M. Natural history and\u00a0decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J\u00a0Antimicrob Chemother 2016; 71(10): 2729\u201339. 10.1093\/jac\/dkw221https:\/\/doi.org\/10.1093\/jac\/dkw221"},{"key":"B5","series-title":"J\u00a0Hosp Infect","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jhin.2020.12.013","article-title":"The daily direct costs of isolating patients identified with highly resistant micro-organisms in a non-outbreak setting","volume":"109","author":"Van Dijk MD","year":"2021","unstructured":"Van Dijk MD, Voor In 'T Holt AF, Polinder S, Severin JA, Vos MC. The daily direct costs of isolating patients identified with highly resistant micro-organisms in a non-outbreak setting. J\u00a0Hosp Infect 2021; 109: 88\u201395. 10.1016\/j.jhin.2020.12.013https:\/\/doi.org\/10.1016\/j.jhin.2020.12.013"},{"issue":"1","key":"B6","series-title":"Infect Control & Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/ice.2017.258","article-title":"Direct costs of a contact isolation day: a prospective cost analysis at a Swiss university hospital","volume":"39","author":"Roth JA","year":"2018","unstructured":"Roth JA, Hornung-Winter C, Radicke I, Hug BL, Biedert M, Abshagen C, et\u00a0al. Direct costs of a contact isolation day: a prospective cost analysis at a Swiss university hospital. Infect Control & Hosp Epidemiol 2018; 39(1): 101\u20133. 10.1017\/ice.2017.258https:\/\/doi.org\/10.1017\/ice.2017.258"},{"key":"B7","series-title":"Embracing a one health framework to fight antimicrobial resistance","doi-asserted-by":"publisher","DOI":"10.1787\/ce44c755-en","author":"OECD","year":"2023","unstructured":"OECD. Embracing a one health framework to fight antimicrobial resistance. Paris: OECD Publishing; 2023. 10.1787\/ce44c755-enhttps:\/\/doi.org\/10.1787\/ce44c755-en"},{"key":"B8","series-title":"National healthcare-associated infections surveillance network (USHIESA)","author":"Republic of Turkey Ministry of Health","year":"2025","unstructured":"Republic of Turkey Ministry of Health. National healthcare-associated infections surveillance network (USHIESA) Report, 2024. Ankara: Republic of Turkey Ministry of Health; 2025. https:\/\/hsgm.saglik.gov.tr\/tr\/dokumanlar-bulasicihastaliklar\/bulasici-raporlar.html#:\u223c:text=USHIESA%20%C3%96zet%20Raporu%202024."},{"key":"B9","series-title":"Antimicrobial resistance surveillance in Europe 2021 data","year":"2023","unstructured":"Antimicrobial resistance surveillance in Europe 2021 data. Stockholm: European Centre for Disease Prevention and Control and World Health Organization; 2023. https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289058537."},{"issue":"11","key":"B10","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.cmi.2025.05.019","article-title":"Antibiotic resistance in Turkiye: what has been done and what needs to be done urgently?","volume":"31","author":"Alhan O","year":"2025","unstructured":"Alhan O, Ozger HS, Karatuna O, Azap OK, Madran B, Keske S, et\u00a0al. Antibiotic resistance in Turkiye: what has been done and what needs to be done urgently? Clin Microbiol Infect 2025; 31(11): 1771\u20134. 10.1016\/j.cmi.2025.05.019https:\/\/doi.org\/10.1016\/j.cmi.2025.05.019"},{"issue":"2","key":"B11","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/ice.2017.245","article-title":"Duration of contact precautions for acute-care settings","volume":"39","author":"Banach DB","year":"2018","unstructured":"Banach DB, Bearman G, Barnden M, Hanrahan JA, Leekha S, Morgan DJ, et\u00a0al. Duration of contact precautions for acute-care settings. Infect Control Hosp Epidemiol 2018; 39(2): 127\u201344. 10.1017\/ice.2017.245https:\/\/doi.org\/10.1017\/ice.2017.245"},{"issue":"1","key":"B12","series-title":"Antimicrob Steward Healthc Epidemiol","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.429","article-title":"Personalized infection prevention and control: a concept whose time has arrived","volume":"3","author":"Savoldi A","year":"2023","unstructured":"Savoldi A, Mutters NT, Tacconelli E. Personalized infection prevention and control: a concept whose time has arrived. Antimicrob Steward Healthc Epidemiol 2023; 3(1): e151. 10.1017\/ash.2023.429https:\/\/doi.org\/10.1017\/ash.2023.429"},{"issue":"4","key":"B13","series-title":"Diagn Microbiol Infect Dis","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.diagmicrobio.2016.05.012","article-title":"Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013","volume":"85","author":"Zarakolu P","year":"2016","unstructured":"Zarakolu P, Eser OK, Aladag E, Al-Zahrani IA, Day KM, Atmaca O, et\u00a0al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013. Diagn Microbiol Infect Dis 2016; 85(4): 466\u201370. 10.1016\/j.diagmicrobio.2016.05.012https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.05.012"},{"issue":"2","key":"B14","series-title":"J\u00a0Mol Diagn","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jmoldx.2019.10.004","article-title":"Evaluation of the BD MAX check-points CPO assay for the detection of Carbapenemase producers directly from rectal swabs","volume":"22","author":"Girlich D","year":"2020","unstructured":"Girlich D, Oueslati S, Bernabeu S, Langlois I, Begasse C, Arangia N, et\u00a0al. Evaluation of the BD MAX check-points CPO assay for the detection of Carbapenemase producers directly from rectal swabs. J\u00a0Mol Diagn 2020; 22(2): 294\u2013300. 10.1016\/j.jmoldx.2019.10.004https:\/\/doi.org\/10.1016\/j.jmoldx.2019.10.004"},{"issue":"5","key":"B15","series-title":"J\u00a0Clin Lab Anal","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/jcla.21620","article-title":"Risk factors for intensive care unit acquired nasal colonization of MRSA and its impact on MRSA infection","volume":"27","author":"Altinbas A","year":"2013","unstructured":"Altinbas A, Shorbagi A, Ascioglu S, Zarakolu P, Cetinkaya-Sardan Y. Risk factors for intensive care unit acquired nasal colonization of MRSA and its impact on MRSA infection. J\u00a0Clin Lab Anal 2013; 27(5): 412\u20137. 10.1002\/jcla.21620https:\/\/doi.org\/10.1002\/jcla.21620"},{"issue":"19","key":"B16","series-title":"Healthcare (Basel)","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11192641","article-title":"Cessation of rectal screening for vancomycin-resistant enterococci: experience from a tertiary care hospital from Turkiye","volume":"11","author":"Telli Dizman G","year":"2023","unstructured":"Telli Dizman G, Metan G, Zarakolu P, Tanriverdi ES, Hazirolan G, Aytac Ak H, et al. Cessation of rectal screening for vancomycin-resistant enterococci: experience from a tertiary care hospital from Turkiye. Healthcare (Basel) 2023; 11(19). 10.3390\/healthcare11192641https:\/\/doi.org\/10.3390\/healthcare11192641"},{"issue":"8","key":"B17","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1017\/ice.2015.82","article-title":"Risk factors for recurrence of carbapenem-resistant Enterobacteriaceae carriage: case-control study","volume":"36","author":"Bart Y","year":"2015","unstructured":"Bart Y, Paul M, Eluk O, Geffen Y, Rabino G, Hussein K. Risk factors for recurrence of carbapenem-resistant Enterobacteriaceae carriage: case-control study. Infect Control Hosp Epidemiol 2015; 36(8): 936\u201341. 10.1017\/ice.2015.82https:\/\/doi.org\/10.1017\/ice.2015.82"},{"issue":"5","key":"B18","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/cid\/ciaa123","article-title":"National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions","volume":"72","author":"Ben-David D","year":"2021","unstructured":"Ben-David D, Masarwa S, Fallach N, Temkin E, Solter E, Carmeli Y, et\u00a0al. National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions. Clin Infect Dis 2021; 72(5): 829\u201335. 10.1093\/cid\/ciaa123https:\/\/doi.org\/10.1093\/cid\/ciaa123"},{"issue":"10","key":"B19","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"1518 e1","DOI":"10.1016\/j.cmi.2021.05.045","article-title":"The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study","volume":"27","author":"Dickstein Y","year":"2021","unstructured":"Dickstein Y, Solter E, Schwartz D, Nutman A, Harevrich I, Wulffhart L, et\u00a0al. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study. Clin Microbiol Infect 2021; 27(10): 1518 e1\u2013e3. 10.1016\/j.cmi.2021.05.045https:\/\/doi.org\/10.1016\/j.cmi.2021.05.045"},{"key":"B20","series-title":"J Hosp Infect","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhin.2024.01.020","article-title":"Comparison of clinical outcomes of patients with serial negative surveillance cultures according to a subsequent polymerase chain reaction test for carbapenemase-producing Enterobacterales","volume":"146","author":"Seo H","year":"2024","unstructured":"Seo H, Kim S, Lee YW, Oh HS, Kim HS, Kim YK. Comparison of clinical outcomes of patients with serial negative surveillance cultures according to a subsequent polymerase chain reaction test for carbapenemase-producing Enterobacterales. J Hosp Infect 2024; 146: 93\u2013101. 10.1016\/j.jhin.2024.01.020https:\/\/doi.org\/10.1016\/j.jhin.2024.01.020"},{"issue":"8","key":"B21","series-title":"Am J Infect Control","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ajic.2019.02.006","article-title":"Assessment of current methicillin-resistant Staphylococcus aureus screening protocols and outcomes at an academic medical center","volume":"47","author":"Richards V","year":"2019","unstructured":"Richards V, Tremblay E. Assessment of current methicillin-resistant Staphylococcus aureus screening protocols and outcomes at an academic medical center. Am J Infect Control 2019; 47(8): 906\u201310. 10.1016\/j.ajic.2019.02.006https:\/\/doi.org\/10.1016\/j.ajic.2019.02.006"},{"issue":"4","key":"B22","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1017\/ice.2019.15","article-title":"A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization","volume":"40","author":"Hughes HY","year":"2019","unstructured":"Hughes HY, Odom RT, Michelin AV, Snitkin ES, Sinaii N, Milstone AM, et\u00a0al. A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization. Infect Control Hosp Epidemiol 2019; 40(4): 414\u20139. 10.1017\/ice.2019.15https:\/\/doi.org\/10.1017\/ice.2019.15"},{"issue":"10","key":"B23","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1086\/323762","article-title":"Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of \u201cclearance\u201d","volume":"33","author":"Baden LR","year":"2001","unstructured":"Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, et\u00a0al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of \u201cclearance\u201d. Clin Infect Dis 2001; 33(10): 1654\u201360. 10.1086\/323762https:\/\/doi.org\/10.1086\/323762"},{"issue":"4","key":"B24","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1086\/502036","article-title":"Duration of colonization with vancomycin-resistant Enterococcus","volume":"23","author":"Byers KE","year":"2002","unstructured":"Byers KE, Anglim AM, Anneski CJ, Farr BM. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002; 23(4): 207\u201311. 10.1086\/502036https:\/\/doi.org\/10.1086\/502036"},{"issue":"1","key":"B25","series-title":"Am J Infect Control","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajic.2016.05.030","article-title":"When should contact precautions be discontinued for patients with methicillin-resistant Staphylococcus aureus?","volume":"45","author":"Richey LE","year":"2017","unstructured":"Richey LE, Oh Y, Tchamba DM, Engle M, Formby LS, Salgado CD. When should contact precautions be discontinued for patients with methicillin-resistant Staphylococcus aureus? Am J Infect Control 2017; 45(1): 75\u20136. 10.1016\/j.ajic.2016.05.030https:\/\/doi.org\/10.1016\/j.ajic.2016.05.030"},{"key":"B1","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli E","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et\u00a0al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20: 1\u201355. 10.1111\/1469-0691.12427https:\/\/doi.org\/10.1111\/1469-0691.12427"},{"issue":"5","key":"B2","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"470 e1","DOI":"10.1016\/j.cmi.2014.12.015","article-title":"Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders\u00a0and rectal KPC concentration","volume":"21","author":"Lerner A","year":"2015","unstructured":"Lerner A, Adler A, Abu-Hanna J, Cohen Percia S, Kazma Matalon M, Carmeli Y. Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders\u00a0and rectal KPC concentration. Clin Microbiol Infect 2015; 21(5): 470 e1\u20137. 10.1016\/j.cmi.2014.12.015https:\/\/doi.org\/10.1016\/j.cmi.2014.12.015"},{"issue":"1","key":"B3","series-title":"Antimicrob Steward Healthc Epidemiol","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2025.173","article-title":"Prioritizing isolation precautions: a patient-centered approach to infection prevention and control","volume":"5","author":"Alp Mese E","year":"2025","unstructured":"Alp Mese E, Carrara E, Tartari E, Mutters NT, Tsioutis C, Birgand G, et\u00a0al. Prioritizing isolation precautions: a patient-centered approach to infection prevention and control. Antimicrob Steward Healthc Epidemiol 2025; 5(1): e123. 10.1017\/ash.2025.173https:\/\/doi.org\/10.1017\/ash.2025.173"},{"issue":"10","key":"B4","series-title":"J\u00a0Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/jac\/dkw221","article-title":"Natural history and\u00a0decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis","volume":"71","author":"Bar-Yoseph H","year":"2016","unstructured":"Bar-Yoseph H, Hussein K, Braun E, Paul M. Natural history and\u00a0decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J\u00a0Antimicrob Chemother 2016; 71(10): 2729\u201339. 10.1093\/jac\/dkw221https:\/\/doi.org\/10.1093\/jac\/dkw221"},{"key":"B5","series-title":"J\u00a0Hosp Infect","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jhin.2020.12.013","article-title":"The daily direct costs of isolating patients identified with highly resistant micro-organisms in a non-outbreak setting","volume":"109","author":"Van Dijk MD","year":"2021","unstructured":"Van Dijk MD, Voor In 'T Holt AF, Polinder S, Severin JA, Vos MC. The daily direct costs of isolating patients identified with highly resistant micro-organisms in a non-outbreak setting. J\u00a0Hosp Infect 2021; 109: 88\u201395. 10.1016\/j.jhin.2020.12.013https:\/\/doi.org\/10.1016\/j.jhin.2020.12.013"},{"issue":"1","key":"B6","series-title":"Infect Control & Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/ice.2017.258","article-title":"Direct costs of a contact isolation day: a prospective cost analysis at a Swiss university hospital","volume":"39","author":"Roth JA","year":"2018","unstructured":"Roth JA, Hornung-Winter C, Radicke I, Hug BL, Biedert M, Abshagen C, et\u00a0al. Direct costs of a contact isolation day: a prospective cost analysis at a Swiss university hospital. Infect Control & Hosp Epidemiol 2018; 39(1): 101\u20133. 10.1017\/ice.2017.258https:\/\/doi.org\/10.1017\/ice.2017.258"},{"key":"B7","series-title":"Embracing a one health framework to fight antimicrobial resistance","doi-asserted-by":"publisher","DOI":"10.1787\/ce44c755-en","author":"OECD","year":"2023","unstructured":"OECD. Embracing a one health framework to fight antimicrobial resistance. Paris: OECD Publishing; 2023. 10.1787\/ce44c755-enhttps:\/\/doi.org\/10.1787\/ce44c755-en"},{"key":"B8","series-title":"National healthcare-associated infections surveillance network (USHIESA)","author":"Republic of Turkey Ministry of Health","year":"2025","unstructured":"Republic of Turkey Ministry of Health. National healthcare-associated infections surveillance network (USHIESA) Report, 2024. Ankara: Republic of Turkey Ministry of Health; 2025. https:\/\/hsgm.saglik.gov.tr\/tr\/dokumanlar-bulasicihastaliklar\/bulasici-raporlar.html#:\u223c:text=USHIESA%20%C3%96zet%20Raporu%202024."},{"key":"B9","series-title":"Antimicrobial resistance surveillance in Europe 2021 data","year":"2023","unstructured":"Antimicrobial resistance surveillance in Europe 2021 data. Stockholm: European Centre for Disease Prevention and Control and World Health Organization; 2023. https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289058537."},{"issue":"11","key":"B10","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.cmi.2025.05.019","article-title":"Antibiotic resistance in Turkiye: what has been done and what needs to be done urgently?","volume":"31","author":"Alhan O","year":"2025","unstructured":"Alhan O, Ozger HS, Karatuna O, Azap OK, Madran B, Keske S, et\u00a0al. Antibiotic resistance in Turkiye: what has been done and what needs to be done urgently? Clin Microbiol Infect 2025; 31(11): 1771\u20134. 10.1016\/j.cmi.2025.05.019https:\/\/doi.org\/10.1016\/j.cmi.2025.05.019"},{"issue":"2","key":"B11","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/ice.2017.245","article-title":"Duration of contact precautions for acute-care settings","volume":"39","author":"Banach DB","year":"2018","unstructured":"Banach DB, Bearman G, Barnden M, Hanrahan JA, Leekha S, Morgan DJ, et\u00a0al. Duration of contact precautions for acute-care settings. Infect Control Hosp Epidemiol 2018; 39(2): 127\u201344. 10.1017\/ice.2017.245https:\/\/doi.org\/10.1017\/ice.2017.245"},{"issue":"1","key":"B12","series-title":"Antimicrob Steward Healthc Epidemiol","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.429","article-title":"Personalized infection prevention and control: a concept whose time has arrived","volume":"3","author":"Savoldi A","year":"2023","unstructured":"Savoldi A, Mutters NT, Tacconelli E. Personalized infection prevention and control: a concept whose time has arrived. Antimicrob Steward Healthc Epidemiol 2023; 3(1): e151. 10.1017\/ash.2023.429https:\/\/doi.org\/10.1017\/ash.2023.429"},{"issue":"4","key":"B13","series-title":"Diagn Microbiol Infect Dis","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.diagmicrobio.2016.05.012","article-title":"Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013","volume":"85","author":"Zarakolu P","year":"2016","unstructured":"Zarakolu P, Eser OK, Aladag E, Al-Zahrani IA, Day KM, Atmaca O, et\u00a0al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013. Diagn Microbiol Infect Dis 2016; 85(4): 466\u201370. 10.1016\/j.diagmicrobio.2016.05.012https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.05.012"},{"issue":"2","key":"B14","series-title":"J\u00a0Mol Diagn","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jmoldx.2019.10.004","article-title":"Evaluation of the BD MAX check-points CPO assay for the detection of Carbapenemase producers directly from rectal swabs","volume":"22","author":"Girlich D","year":"2020","unstructured":"Girlich D, Oueslati S, Bernabeu S, Langlois I, Begasse C, Arangia N, et\u00a0al. Evaluation of the BD MAX check-points CPO assay for the detection of Carbapenemase producers directly from rectal swabs. J\u00a0Mol Diagn 2020; 22(2): 294\u2013300. 10.1016\/j.jmoldx.2019.10.004https:\/\/doi.org\/10.1016\/j.jmoldx.2019.10.004"},{"issue":"5","key":"B15","series-title":"J\u00a0Clin Lab Anal","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/jcla.21620","article-title":"Risk factors for intensive care unit acquired nasal colonization of MRSA and its impact on MRSA infection","volume":"27","author":"Altinbas A","year":"2013","unstructured":"Altinbas A, Shorbagi A, Ascioglu S, Zarakolu P, Cetinkaya-Sardan Y. Risk factors for intensive care unit acquired nasal colonization of MRSA and its impact on MRSA infection. J\u00a0Clin Lab Anal 2013; 27(5): 412\u20137. 10.1002\/jcla.21620https:\/\/doi.org\/10.1002\/jcla.21620"},{"issue":"19","key":"B16","series-title":"Healthcare (Basel)","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11192641","article-title":"Cessation of rectal screening for vancomycin-resistant enterococci: experience from a tertiary care hospital from Turkiye","volume":"11","author":"Telli Dizman G","year":"2023","unstructured":"Telli Dizman G, Metan G, Zarakolu P, Tanriverdi ES, Hazirolan G, Aytac Ak H, et al. Cessation of rectal screening for vancomycin-resistant enterococci: experience from a tertiary care hospital from Turkiye. Healthcare (Basel) 2023; 11(19). 10.3390\/healthcare11192641https:\/\/doi.org\/10.3390\/healthcare11192641"},{"issue":"8","key":"B17","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1017\/ice.2015.82","article-title":"Risk factors for recurrence of carbapenem-resistant Enterobacteriaceae carriage: case-control study","volume":"36","author":"Bart Y","year":"2015","unstructured":"Bart Y, Paul M, Eluk O, Geffen Y, Rabino G, Hussein K. Risk factors for recurrence of carbapenem-resistant Enterobacteriaceae carriage: case-control study. Infect Control Hosp Epidemiol 2015; 36(8): 936\u201341. 10.1017\/ice.2015.82https:\/\/doi.org\/10.1017\/ice.2015.82"},{"issue":"5","key":"B18","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/cid\/ciaa123","article-title":"National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions","volume":"72","author":"Ben-David D","year":"2021","unstructured":"Ben-David D, Masarwa S, Fallach N, Temkin E, Solter E, Carmeli Y, et\u00a0al. National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions. Clin Infect Dis 2021; 72(5): 829\u201335. 10.1093\/cid\/ciaa123https:\/\/doi.org\/10.1093\/cid\/ciaa123"},{"issue":"10","key":"B19","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"1518 e1","DOI":"10.1016\/j.cmi.2021.05.045","article-title":"The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study","volume":"27","author":"Dickstein Y","year":"2021","unstructured":"Dickstein Y, Solter E, Schwartz D, Nutman A, Harevrich I, Wulffhart L, et\u00a0al. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study. Clin Microbiol Infect 2021; 27(10): 1518 e1\u2013e3. 10.1016\/j.cmi.2021.05.045https:\/\/doi.org\/10.1016\/j.cmi.2021.05.045"},{"key":"B20","series-title":"J Hosp Infect","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhin.2024.01.020","article-title":"Comparison of clinical outcomes of patients with serial negative surveillance cultures according to a subsequent polymerase chain reaction test for carbapenemase-producing Enterobacterales","volume":"146","author":"Seo H","year":"2024","unstructured":"Seo H, Kim S, Lee YW, Oh HS, Kim HS, Kim YK. Comparison of clinical outcomes of patients with serial negative surveillance cultures according to a subsequent polymerase chain reaction test for carbapenemase-producing Enterobacterales. J Hosp Infect 2024; 146: 93\u2013101. 10.1016\/j.jhin.2024.01.020https:\/\/doi.org\/10.1016\/j.jhin.2024.01.020"},{"issue":"8","key":"B21","series-title":"Am J Infect Control","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ajic.2019.02.006","article-title":"Assessment of current methicillin-resistant Staphylococcus aureus screening protocols and outcomes at an academic medical center","volume":"47","author":"Richards V","year":"2019","unstructured":"Richards V, Tremblay E. Assessment of current methicillin-resistant Staphylococcus aureus screening protocols and outcomes at an academic medical center. Am J Infect Control 2019; 47(8): 906\u201310. 10.1016\/j.ajic.2019.02.006https:\/\/doi.org\/10.1016\/j.ajic.2019.02.006"},{"issue":"4","key":"B22","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1017\/ice.2019.15","article-title":"A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization","volume":"40","author":"Hughes HY","year":"2019","unstructured":"Hughes HY, Odom RT, Michelin AV, Snitkin ES, Sinaii N, Milstone AM, et\u00a0al. A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization. Infect Control Hosp Epidemiol 2019; 40(4): 414\u20139. 10.1017\/ice.2019.15https:\/\/doi.org\/10.1017\/ice.2019.15"},{"issue":"10","key":"B23","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1086\/323762","article-title":"Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of \u201cclearance\u201d","volume":"33","author":"Baden LR","year":"2001","unstructured":"Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, et\u00a0al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of \u201cclearance\u201d. Clin Infect Dis 2001; 33(10): 1654\u201360. 10.1086\/323762https:\/\/doi.org\/10.1086\/323762"},{"issue":"4","key":"B24","series-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1086\/502036","article-title":"Duration of colonization with vancomycin-resistant Enterococcus","volume":"23","author":"Byers KE","year":"2002","unstructured":"Byers KE, Anglim AM, Anneski CJ, Farr BM. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002; 23(4): 207\u201311. 10.1086\/502036https:\/\/doi.org\/10.1086\/502036"},{"issue":"1","key":"B25","series-title":"Am J Infect Control","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajic.2016.05.030","article-title":"When should contact precautions be discontinued for patients with methicillin-resistant Staphylococcus aureus?","volume":"45","author":"Richey LE","year":"2017","unstructured":"Richey LE, Oh Y, Tchamba DM, Engle M, Formby LS, Salgado CD. When should contact precautions be discontinued for patients with methicillin-resistant Staphylococcus aureus? Am J Infect Control 2017; 45(1): 75\u20136. 10.1016\/j.ajic.2016.05.030https:\/\/doi.org\/10.1016\/j.ajic.2016.05.030"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/030\/73\/2\/article-p194.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/030\/73\/2\/article-p194.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/030\/73\/2\/article-p194.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:13:52Z","timestamp":1780074832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/030\/73\/2\/article-p194.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":50,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1556\/030.2026.02900","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}